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endocardial scar,4 isolation of this tissue by encircling
endocardial ventriculotomy,5 encircling endocardial
cryoablation,6 or laser irradiation.7 In contrast to previ-
ous reports detailing the importance of intraoperative
mapping,8-10 series of visually guided resections with-
out mapping achieved results similar to those obtained
with map-guided procedures.11,12 The goal of this study
was to evaluate, by retrospective analysis, the outcomes
of patients who underwent large encircling cryoabla-
tions without mapping for refractory VT after anterior
MI. This is the largest reported series of patients treat-
ed by this method in which follow-up was continued up
to 10 years.
Patients and methods
Patients. Between 1985 and 1996, 38 patients (34 male, 4
female) underwent surgery for spontaneous, sustained VT
after MI. The mean patient age was 62.1 ± 7.3 years (range
41-72 years). The mean interval between the operation and MI
was 59.2 months (range 3 weeks–24 years); 7 patients
(18.4%) underwent surgery within 1 month of MI. The mean
left ventricular ejection fraction (LVEF) was 29.0% ± 7.2%
P ercutaneous catheter ablation1 and nonthoracotomyimplantation of automatic implantable cardioverter
defibrillators (AICDs)2 have decreased the number of
direct operations performed for life-threatening ventric-
ular tachycardia (VT) after myocardial infarction (MI).
However, for these patients direct surgical ablation
combined with aneurysm resection and myocardial
revascularization remains the most powerful curative
tool. Among several direct surgical procedures, two
major approaches have become prevalent: (1) elective
procedures, with ablation of arrhythmogenic foci after
precise localization by intraoperative mapping3; (2)
extensive procedures such as the total removal of the
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(range 15%-45%) and the mean left ventricular end-diastolic
pressure was 14.8 ± 7.3 mm Hg (range 4-35 mm Hg). On
coronary angiogram, 21 (55%) had 1-vessel disease, 11
(29%) had 2-vessel disease, and 6 (16%) had 3-vessel dis-
ease. The VT was monomorphic in 28 (74%) patients and
polymorphic in 10 (26%). Twelve patients (31.5%) had more
than 5 episodes of malignant arrhythmias and 25 patients
(65.7%) had repeated VT that could be stopped only by car-
dioversion, with an average of 3 cardioversions per patient.
The mean number of antiarrhythmic drug trials was 2.5 per
patient (range 1-6), with amiodarone (200-400 mg daily)
administered to all 38 patients (100%).
Methods.
Indications. All patients had an anterior MI. They were
referred for surgical treatment (1) if their VT was unrespon-
sive to medical treatment or the antiarrhythmic medications
had to be stopped because of major side effects or (2) if there
was an indication of associated disease, such as congestive
heart failure over an anteroapical aneurysm or angina with
graftable coronary arteries.
Low ejection fraction was not considered a contraindica-
tion, especially in the presence of a large anteroapical aneur-
ysm. However, patients with poor contraction of the other
segments on the right or left anterior oblique projection of the
ventriculogram, or on the echocardiogram, and/or diffuse
coronary disease with target vessels less than 1.5 mm, were
not selected for this type of operation and were referred for
AICD implantation.
Preoperative study protocol. The preoperative study proto-
col included a Holter electrocardiogram (ECG), echocardio-
gram, cardiac catheterization, coronary arteriogram, and
electrophysiologic studies (EPS). EPS were performed 24 to
48 hours after antiarrhythmic drug cessation in 28 (73.6%)
patients who were in stable condition. The stimulation proto-
col consisted in apical ventricular premature beats (1, 2, and
up to 3 extrastimuli) with increasing prematurity on a 500-ms
basic cycle length. A sustained VT was the end point of the
EPS protocol. Ten (26.3%) patients who were in unstable
condition were deemed unsuitable for preoperative EPS.
Operative technique. During cardiopulmonary bypass, when
cooling to moderate hypothermia (28°C) when necessary, the
proximal saphenous vein graft anastomosis was performed
first. With the aid of cardioplegic arrest, the ablative proce-
dure was carried out by way of a left ventriculotomy through
the scar, as first described by Guiraudon and associates,13
without mapping. Points of cryolesion were either edge to
edge or overlapping and applied 1.5 cm outside the area of
the visible scar in all patients. In the septum, where the exact
delimitation of the scar is less easy, this distance of 1.5 cm
was increased so that a second row could be applied. Care
was taken to avoid ablation in the upper part of the septum
near its membranous portion, which can cause a His bundle
block (which happened twice at the beginning of our experi-
ence). Cryoablation was performed with a Frigitronics
cryosurgical system CCS 100 with a 15-mm diameter flat
face curved probe (CooperSurgical Inc, Shelton, Conn). A
mean of 11.4 ± 2.2 cryolesions (range 8-15) was realized at a
mean temperature of –61°C (range –50°C to –74°C) for 2
minutes per point. The principal associated procedures were
aneurysmectomy and coronary artery bypass surgery. Thirty-
eight (100%) patients underwent aneurysmectomy, with a
Jatene procedure in 12 (31.5%). The 12 (31.5%) patients who
required coronary artery bypass received a total of 18 grafts
(mean 1.5 grafts per patient). The mean cardiopulmonary by-
pass time was 109 ± 45 minutes (range 48-251 minutes), and
the average crossclamp time was 37 ± 24 minutes (range 25-
94 minutes).
Postoperative protocol. At postoperative day 14, the patients
were subjected to EPS with the same protocol as used before
the operation, by way of the temporary right ventricular epi-
cardial leads, as well as a Holter ECG, and echocardiogram.
After EPS, patients were maintained on a program of amio-
darone (200 mg daily) for 6 months, which was subsequently
discontinued except in the presence of abnormal EPS or
Holter ECG findings during the postoperative period or in the
presence of atrial fibrillation. 
Evaluation and definitions. Results of EPS were considered
abnormal only if a sustained VT (>30 seconds) was inducible,
irrespective of its morphology. Electrical success was defined
by abnormal EPS and Holter ECG results during the postoper-
ative period. Clinical success was defined by the absence of
spontaneous VT with or without antiarrhythmic medication
after surgery (corresponding to freedom from VT). Sudden car-
diac death, defined as death occurring within 1 hour of onset of
symptoms in an otherwise clinically stable patient, was con-
sidered as recurrent VT. Heart transplantation during the fol-
low-up was counted as death from congestive heart failure.
Follow-up. Patients were traced for a mean follow-up of
61.9 ± 38.5 months (range 3-124 months). One Portugese
patient was lost to follow-up at 3 months. He was included in
the in-hospital results but was eliminated from rough long-
term results. He was included in the actuarial results as cen-
sored data. Data were obtained via questionnaires to the
patient’s referring physician and cardiologist or by consulta-
tion in the outpatient clinic of the Cardiology Unit of Arnaud
de Villeneuve Hospital.
Statistical analysis. Preoperative and perioperative data
were obtained by reviewing the patients’ hospital records. All
data were entered into a computer for statistical analysis with
SAS statistical software (SAS Institute, Inc, Cary, NC) at the
medical statistics department of the hospital. Data are ex-
pressed as a mean ± standard deviation. Statistical analysis was
performed by Wilcoxon paired t test for comparison between 2
periods. Actuarial survival and freedom-from-events curves
were prepared according to the Kaplan-Meier method.
Results
Mortality. Early mortality (within 30 days) after large
encircling cryoablation was 2.6% (1 patient). This 67-
year-old male patient died of congestive heart failure
on postoperative day 17 and had been operated on for
recurrent VT within the first month after anterior MI.
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His preoperative LVEF was 25%; hypokinesia of the
inferior wall was associated with a previous inferior
MI. The encircling cryoablative procedure was ad-
dressed only to the anterior scar.
Late mortality after surgery was 44.4% (16/36
patients): 38.8% (14 patients) died, and 5.5% (2
patients) underwent heart transplantation. The main
cause of death was congestive heart failure (62.6% of
late mortality), but sudden cardiac death occurred in
5.5% (2 patients). At 5 and 7 years, the overall actuari-
al survivals (Fig 1) were 63% (95% CI 47%-80%) and
42% (95% CI 22%-63%), respectively. Freedom from
Fig 1. Solid line, Overall actuarial survival (operative mortality included) at 7 years (Kaplan-Meier method, 95% CI
22%-63%). Broken line, Freedom from sudden cardiac death at 7 years (Kaplan-Meier method, 95% CI 80%-100%).
Fig 2. Actuarial rate of freedom from VT at 7 years (Kaplan-Meier method, 95% CI 61%-94%).
sudden cardiac death was 91% (95% CI 80%-100%) at
both 5 and 7 years.
Morbidity. Early morbidity included 8 patients
(21.6%) with low cardiac output (1 of 8 had an intra-
aortic balloon insertion) and 2 patients (5.4%) with
complete heart block had a pacemaker insertion. Late
morbidity included AICD implantation for malignant
recurrent VT in 1 (2.7%) patient and residual angina in
2 patients (5.5% of survivors).
Rhythm. The electrical success rate based on post-
operative EPS was 94.5% (35/37 survivors). One
patient had polymorphic sustained VT, but VT did not
develop during follow-up. Another patient had mono-
morphic sustained VT comparable with the preopera-
tive VT; this patient had a nonfatal recurrent VT during
follow-up. In a third patient with polymorphic nonsus-
tained VT, the procedure was not considered to have
been a failure according to the aforementioned defini-
tion. Two patients had a VT recorded on Holter ECG or
on intensive care unit monitoring. They had nonfatal
recurrent VT during follow-up. The overall electrical
success rate was 89.1% (33/37 survivors).
The clinical success rate was 83.3% (30/36 sur-
vivors). Six patients (16.7%) had arrhythmias that could
not be controlled. Two of these 6 patients died of sud-
den cardiac death at 21 and 48 months, and 4 patients
had nonfatal recurrent VT. Freedom from VT was 77%
(95% CI 61%-94%) at both 5 and 7 years (Fig 2).
Ventricular function. After the operation, LVEF
improved significantly, from 29.0% ± 7.2% to 36.6% ±
11.2% (P = .0106).
Discussion
Progress in understanding the origin of ischemic VT,
whose mechanisms were described by Josephson and
associates,14 led to the first direct approach to its treat-
ment: subendocardial resection, limited and guided by
intraoperative mapping.3 With this procedure, the best
electrical success rates improved from 66%15 to 91%.16
Subsequent developments in the direct treatment of
ischemic VT further increased success rates. The intro-
duction of computerized mapping, sequential endocar-
dial resection, and the combined use of these proce-
dures increased this success rate consistently to more
than 90%.8,17,18 In attempts to avoid the limitations of
intraoperative mapping, Moran and colleagues4 de-
scribed a technique of large endocardial resection with-
out mapping for which the electrical success rate was
92%. In contrast, Guiraudon and colleagues abandoned
encircling endocardial venticulotomy5 and later de-
scribed encircling endocardial cryoablation, with suc-
cess rates up to 93%6 without the deleterious effects of
the circular endoventricular incision.
After initial experiences with map-guided subendo-
cardial resection and localized cryolesions, we turned
to large encircling cryoablation without mapping. This
decision was influenced by our observations that, espe-
cially with quadripolar hand-held electrodes, mapping
was not successful in all patients after ventriculotomy
(mapping success rate of 63%, unpublished data).
Moreover, in the majority of patients with anterior MI,
the earliest activation or cryotermination site was locat-
ed within the area of the visible scar tissue. Although
large blind endocardiectomy has produced consistently
high success rates,4,11 the arduous nature of this proce-
dure—particularly when performed on mitral papillary
muscle or interventricular septum—compelled us to
perform large encircling cryoablation.
Although unsuccessful mapping or “no mapping” has
been documented as a prominent risk factor for failure
by several authors,9.10,23 it was not a significant factor
of failure in some series.19-22 Even with computerized
mapping, with which one can achieve a 100% rate of
successful mapping, the highest electrical success rates
ranged from 72% to 87%.23,24 Results from our large
encircling cryoablations were similar to those obtained
by Guiraudon and associates,13 with an electrical suc-
cess rate of 94.5%. Furthermore, although mapping
was used in their series, they saw no difference in elec-
trical success rates between patients with successful or
unsuccessful intraoperative mapping.20 In addition, as
argued by Guiraudon and colleagues,13 map-guided
surgical procedures were often regional or large proce-
dures rather than truly localized, as assessed by the sur-
gical protocols described in various reports.4,9,17,18
Finally, Cox,8 in his collaborative report, revealed no
significant difference in the postoperative rate of VT
inducibility between 179 patients treated by localized
procedures versus 342 patients treated by generalized
techniques.
We report a post-cryoablation freedom from sudden
cardiac death of 91% (95% CI 80%-100%) at both 5
and 7 years. However, our results concerning overall
survival were far from ideal, with overall actuarial sur-
vivals of 63% (95% CI 47%-80%) and 42% (95% CI
22%-63%) at 5 and 7 years, respectively. This lower
survivorship could be explained, in part, by the mean
length of our postoperative follow-up (61.9 ± 38.5
months), which is significantly longer than is reported
in other studies. Furthermore, unlike other series,23
patients over 65 years old were not rejected from our
series. Moreover, despite an improvement in the post-
operative LVEF, the preoperative LVEF of our series
was 29%. It has been demonstrated that an LVEF of
less than 31% is a strong predictor of late postoperative
mortality.25 Undoubtedly, our revascularization rate of
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31% had been too weak. Mickleborough and associ-
ates,23 in their series, had an 85% rate of coronary
artery bypass, and in many other reports this rate was
about 70%.24,25
Death after operation for ischemic VT is rarely due to
recurrent VT.23 The main cause of late postoperative
death remains congestive heart failure. We believe that
sustained improvements in left ventricular function, by
ventricular remodeling and extensive revasculariza-
tion,23 should improve overall long-term survivals.
Adding a more drastic selection of patients, by using
the quality of the residual left ventricular function as a
criterion for operability,26 in the era of other alterna-
tives1,2 should lead to excellent outcome.
Study limitations. In this series, only 65.7% (25/38)
of patients who underwent large encircling cryoabla-
tion had intractable VT (eg, uncured by preoperative
antiarrhythmic drug treatment). Indications for surgery
in the other 34.3% (13/38) were primarily congestive
heart failure, myocardial ischemia, or both. Amioda-
rone was used before the operation and was stopped the
day of the operation in all responsive patients. Because
of the long-lasting half-life of amiodarone, it is likely
that the electrical success rate based on postoperative
EPS would have been lower if all patients had been
nonresponsive. Moreover, amiodarone treatment was
continued for 6 months after cryoablation, irrespective
of postoperative EPS results. It is possible that our clin-
ical success rate would have been lower if all 38
patients had been nonresponsive to medical therapy.
Conclusion
We believe that one can achieve good results without
intraoperative mapping in the treatment of VT develop-
ing after anterior MI by using large encircling cryoab-
lation according to Guiraudon’s technique. All attempts
should be made to improve left ventricular function to
achieve better long-term survival.
We thank Vergnes Christine, MD, and Marie-Christine
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